Morgan Stanley Direct Lending Fund current report, 12 November 2021

Morgan Stanley Direct Lending Fund — Form 8-K Summary

Business Context and Reporting Period

The Form 8-K reports an equity capital drawdown by Morgan Stanley Direct Lending Fund, a Delaware entity. The earliest reported event occurred on November 12, 2021; the filing was dated November 18, 2021.

Transaction and Key Financial Metrics

  • Shares issued: Approximately 8,231,421 shares of common stock.
  • Aggregate offering price: $175.0 million.
  • Implied issue price: Approximately $21.26 per share, based on the reported aggregate price and share count.
  • Closing date: November 12, 2021.
  • Funding mechanism: Capital drawdown under subscription agreements, requiring stockholders to fund purchases up to their respective capital commitments on an as-needed basis.
  • Notice requirement: At least eight business days’ prior notice to stockholders.
  • Registration status: The issuance was made in reliance on the private-placement exemption under Section 4(a)(2) of the Securities Act and Regulation D.

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, net asset value, or other operating financial metrics.

Material Changes Versus Prior Comparable Period

The filing does not provide a prior-period comparison. The reported transaction increases the Company’s common equity and available capital by $175.0 million before any related expenses.

Guidance, Outlook, Risks, and Unusual Items

No financial guidance, operating outlook, management commentary, contingencies, or unusual items are disclosed. The offering depended in part on stockholder representations that the investors were accredited investors under Regulation D.

Investor Verification Items

  • Verify the final number of shares issued and the actual per-share issuance price from the applicable subscription and closing records.
  • Confirm the effect of the $175.0 million capital drawdown on total committed capital, cash availability, and investment capacity.
  • Review subsequent filings for deployment of the proceeds, changes in net asset value, leverage, and liquidity.
  • Confirm compliance with the private-placement exemption and the accredited-investor representations.